A Randomized, Double-blind, Phase 3 Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer (ENGOT-0V44 The FIRST)
- Suri, Anuj (PI)
- Alaniz, Anne (Key Personnel)
- Singh, Monisha (Key Personnel)
- Zaid, Tarrik (Key Personnel)
Project: Clinical Trial